ORAMED PHARMACEUTICALS INC. - Common Stock (ORMP)

CUSIP: 68403P203

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
+675,849
Put/Call ratio
65%
SEC-reported price per share
$2.18
Number of holders
58
Value change
-$8,600,260
Number of buys
24
Open additional details 1 more signal available
Number of sells
47
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
41,591,959

Security key

68403P203

Report period

Q1 2023

Institutions

58

Top holders

10

Ownership snapshot

Top reported holders of ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MILLENNIUM MANAGEMENT LLC
Disclosed value leader
MILLENNIUM MANAGEMENT LLC
Comparable rows
0/15
Latest evidence
31 Dec 2022
13F Highest disclosed value: $5,897,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

MILLENNIUM MANAGEMENT LLC has the largest disclosed position value at $5.9M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MILLENNIUM MANAGEMENT LLC's linked filing trail.
Disclosed position value Top 5
MILLENNIUM MANAGEMENT LLC $5.9M
JPMORGAN CHASE & CO $4.87M
Lindbrook Capital, LLC $4.61M
MORGAN STANLEY $3.81M
TWO SIGMA ADVISERS, LP $3.03M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$5,897,000
490,203 shares
— 31 Dec 2022
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$4,868,000
404,617 shares
— 31 Dec 2022
Lindbrook Capital, LLC
13F
Company
13F
—
denominator unverified
$4,611,713
383,351 shares
— 31 Dec 2022
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$3,806,183
316,391 shares
— 31 Dec 2022
TWO SIGMA ADVISERS, LP
13F
Company
13F
—
denominator unverified
$3,030,357
251,900 shares
— 31 Dec 2022
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
13F
—
denominator unverified
$2,232,840
185,606 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
58
Shares
4,261,808
Rows available
58
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q4 2025 Across Filers

Q4 2025 holders
57
Q1 2023 holders
58
Holder diff
1
Investor Q4 2025 Shares Q1 2023 Shares Share Diff Share Chg % Q4 2025 value Q1 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .